Showing 1 - 9 results of 9 for search 'Faguang Jin', query time: 0.03s
Refine Results
-
1
-
2
Diagnostic accuracy of rapid on-site evaluation in subtyping lung cancer via bronchoscopic biopsy by Shuang Yan, Hua Jiang, Li Gong, Lei Pan, Faguang Jin
Published 2025-05-01Get full text
Article -
3
Efficacy and safety of inhaled ambroxol hydrochloride solution in patients with lower respiratory tract infectious diseases: a randomized, double-blind, placebo-controlled, multice... by Di Wu, Xiuhua Fu, Faguang Jin, Hui Li, Zhiqiang Qin, Haoyan Wang, Hongmei Yue, Jie Zhang, Zhaolong Cao
Published 2025-07-01Get full text
Article -
4
-
5
Epigallocatechin-3-gallate Ameliorates Seawater Aspiration-Induced Acute Lung Injury via Regulating Inflammatory Cytokines and Inhibiting JAK/STAT1 Pathway in Rats by Wei Liu, Mingqing Dong, Liyan Bo, Congcong Li, Qingqing Liu, Yanyan Li, Lijie Ma, Yonghong Xie, Enqing Fu, Deguang Mu, Lei Pan, Faguang Jin, Zhichao Li
Published 2014-01-01Get full text
Article -
6
-
7
Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial... by Ying Cheng, Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Jing Zhu
Published 2020-04-01Get full text
Article -
8
Safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases: an open-label, single-arm, multicentre study by Jie Zhang, Zhancheng Gao, Xiaohong Chen, Wei Wang, Ting Yang, Gang Chen, Rui Chen, Yi Hu, Xiaohong Yang, Jie Meng, Dan Zhu, Yuanlin Song, Jinping Zheng, Liping Chen, Tianli Wang, Xiaoju Zhang, Xiaoping Ren, Faguang Jin, Zhiyi He, Lin Su, Jinfang Ma, Zhengguang He, Zuke Xiao, Changli Yu, Liangping Mao, Zhenshan Wang, Xianwei Ye, Jianqing Zhao, Keying Xue, Baosong Xie, Ruifeng Zhang, Weiquan Liang, Huili Zhu, Wanjun Yu, Yilan Sun, Shujuan Jiang, Tiantuo Zhang, Gongping Chen
Published 2025-05-01Get full text
Article -
9
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study by Jian Zhang, Ping Lu, Hui Zhao, Jianhua Chen, Wei Shi, Xiubao Ren, Yi Hu, Liping Wang, Hongmei Zhang, Chengchu Zhu, Jianping Xiong, Jianying Zhou, Jun Zhao, Yongqian Shu, Caicun Zhou, Xiaorong Dong, Yunpeng Liu, Yunchao Huang, Jian Zhao, Yiping Zhang, Sheng Hu, Xiaoyan Lin, Yueyin Pan, Jiuwei Cui, Lizhu Lin, Kangsheng Gu, Yun Fan, Qun Chen, Gongyan Chen, Zhehai Wang, Fengying Wu, Guangyu An, Shuliang Guo, Xiaodong Jiang, Yongsheng Wang, Jifeng Feng, Jianhua Shi, QiMing Wang, Jianan Huang, Lejie Cao, Jianhua Chang, Zhiyong He, Jian Fang, Faguang Jin, Hongjun Gao, Cuimin Ding, Xiangdong Zhou, Anwen Liu, Jianjin Huang, Beili Gao, Yinglan Chen, Chengping Hu, Zhigao Wang, Xinjing Ma
Published 2024-11-01Get full text
Article